<li>Maximilian J. Mair, Manfred Mitterer, Pia Gattinger, Julia M. Berger, Wolfgang Trutschnig, Arne C. Bathke, Margaretha Gansterer, Anna S. Berghoff, Severin Laengle, Lynn Gottmann, Thomas Buratti, Helmuth Haslacher, Wolfgang W. Lamm, Markus Raderer, Selma Tobudic, Thorsten Fuereder, Rudolf Valenta, Dominic Fong, Matthias Preusser. <strong>Enhanced SARS-CoV-2 breakthrough infections in patients with hematologic and solid cancers due to Omicron</strong>. <em>Cancer Cell</em>, 2022; DOI: <a href="http://dx.doi.org/10.1016/j.ccell.2022.04.003" rel="nofollow" target="_blank">10.1016/j.ccell.2022.04.003</a>
</li>